Cldn5 expression was significantly elevated in malignant cSCC lesions compared to non-malignant flat warts, suggesting Cldn5 may serve as a prognostic biomarker for EpV-associated skin cancer progression. The gene discussed is CLDN5; the disease is skin cancer.